45 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product under
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
with all statutes, rules and regulations applicable to the testing, development, manufacture, packaging, processing, use, distribution, marketing
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
revenue, our business and our results of operations.
The research, development, testing, manufacturing, labeling, packaging, approval, promotion … on third parties, such as CROs, investigational product packaging, labeling and distribution, laboratories, medical institutions and clinical
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
to generate revenue, our business and our results of operations.
The research, development, testing, manufacturing, labeling, packaging, approval … .
We rely on third parties, such as CROs, investigational product packaging, labeling and distribution, laboratories, medical institutions
8-K
EX-1.1
q7fhgtw7guhi3zde
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
1pql bqxebn
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
lb8vfwy4kykdj8mmury
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
46wk9uqbiizweg0wkg
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-1.1
irl8ialgk93a
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
8y126
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
n4clh
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
8nlt3r1
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
qfr34y7csawbb8lj55
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
zbzoc dot3hgd20
12 Apr 19
Prospectus supplement
4:41pm